10/27/25 (North Chelmsford, Mass.) – In 2006, the Massachusetts Legislature designated October 21 as Massachusetts Biomedical Research Day, to recognize the contributions biomedical research makes to the health and well-being of the citizens of the Commonwealth and people around the world, as well as the many positive impacts that biomedical research has on the region’s economy and reputation. Each year, the Massachusetts Society for Medical Research – the nation’s oldest regional non-profit organization supporting biomedical research – celebrates by honoring those individuals or institutions from across New England who have made significant contributions to the field.

On October 24, the following individuals were honored during the 2024 Biomedical Research Day celebration and honors luncheon, held at Bristol Myers Squibb in East Cambridge, Mass.

The honorees were chosen by the MSMR Board of Directors for their contributions in one of four fields: Investigator, Educator, Business Leader and Government Leader.

The 2025 honorees include:

Investigator – Dr. Giovanni Traverso, Director of the Laboratory for Translational Engineering at MIT and Harvard

Prof. Giovanni Traverso is the Director of the Laboratory for Translational Engineering at MIT and Harvard. He is an Associate Professor in the Department of Mechanical Engineering at MIT, Associate Member of the Broad Institute and a gastroenterologist in the Division of Gastroenterology at Brigham and Women’s Hospital, Harvard Medical School where his early research led to the development of Cologuard, the first FDA-approved non-invasive test for colon cancer screening. During his postdoctoral work at MIT, he advanced new technologies for drug delivery and physiological sensing via the gastrointestinal tract. His current research focuses on developing next-generation therapeutic delivery systems for the gastrointestinal tract and novel ingestible electronic devices for sensing a wide range of physiological and pathophysiological parameters.

Dr. Traverso earned his BA from Trinity College, University of Cambridge, and his Ph.D. from Johns Hopkins University, before completing medical school at the University of Cambridge, internal medicine residency at Brigham and Women’s Hospital and gastroenterology fellowship at the Massachusetts General Hospital.

Educator (co-awardees) – Dr. Margaret Livingstone, Professor of Neurobiology at Harvard Medical School and Dr. Agnes Lacreuse, Professor in the Department of Psychological and Brain Sciences at the University of Massachusetts Amherst

Dr. Margaret Livingstone is Professor of Neurobiology at Harvard Medical School. She has done research on hormones and behavior, learning, dyslexia, and vision. Dr. Livingstone has explored the ways in which vision science can understand and inform the world of visual art. She has written a popular lay book, Vision and Art, which has brought her acclaim in the art world as a scientist who can communicate with artists and art historians, with mutual benefit. She generated some important insights into the field, including a simple explanation for the elusive quality of the Mona Lisa’s smile (it is more visible to peripheral vision than to central vision) and the fact that Rembrandt, like a surprisingly large number of famous artists, was likely to have been stereoblind which is the inability to perceive depth or 3D space.

Dr. Livingstone received her undergraduate degree from MIT and Ph.D. from Harvard University.

Dr. Agnes Lacreuse is Professor in the Department of Psychological and Brain Sciences, a member of the Neuroscience and Behavior Graduate Program, the Initiative of Neurosciences, and Center for Neuroendocrine Studies at the University of Massachusetts Amherst. Her distinguished career has been dedicated to advancing our understanding of neurocognitive aging, with a specific focus on sex differences, Alzheimer’s disease, and women’s health. She studies nonhuman primates to better understand neurocognitive aging and pathological aging processes, such as those involved in Alzheimer’s disease (AD). Additionally, her work aims to develop new treatments that would safely alleviate severe side effects associated with breast cancer to help survivors live a better life.

Dr. Lacreuse received her Ph.D. from Universite Paul Sabatier, Toulouse, France.

Business Leader – Bill Sibold, CEO, Madrigal Pharmaceuticals

Mr. Bill Sibold has more than 30 years of experience in the biopharmaceutical industry and is currently the President & CEO of Madrigal Pharmaceuticals. Prior to joining Madrigal, he served as Executive Vice President, Specialty Care of Sanofi and President, Sanofi North America, where he led a global organization of approximately 10,000 employees across five specialty therapeutic areas and served as a member of the Sanofi Executive Committee. Previously, Mr. Sibold served as Chief Commercial Officer of Avanir Pharmaceuticals, and Senior Vice President U.S. Commercial for Biogen. He also served on the Executive Committee of BIO. Bill joined Madrigal as their CEO in 2023 and has launched the first approved treatment for metabolic dysfunction-associated steatohepatitis a highly prevalent yet underdiagnosed liver disease in patients with other health issues including obesity and type 2 diabetes.

Bill received his BA in Molecular Biophysics and Biochemistry from Yale University and his MBA from Harvard Business School.

Government Leader – Maura Healey, 73_rd Governor of Massachusetts

In her first year as Governor, Healey has already delivered on key promises to help Massachusetts become a leader in clean energy, a more affordable and equitable place to live, and a great place for businesses to operate. During her tenure, Governor Healey has already delivered on key promises to help Massachusetts become a leader in clean energy, a more affordable and equitable place to live, and a great place for businesses to operate. Gov. Healey is an outspoken advocate for the life science sector in the state and has been strong in fighting back against Trump administration cuts to federal research funding. And in November 2024, Gov Healey signed the $4 billion Mass Leads Act, to invest in Massachusetts businesses, create good jobs, and keep the state’s innovation economy the best in the world.

Healey attended Harvard College, where she captained the basketball team, and then spent two years as a 5’4” starting point guard on a professional basketball team in Austria.

Dr. Margaret Livingstone, Bill Sibold and Dr. Giovanni Traverso (left to right) accept their 2025 MSMR Biomedical Research Day awards in the category of Educator, Business Leader and Investigator, respectively from MSMR Board Chairman William Barbo and MSMR President, Aimee Christian, Ph.D. [Not pictured: Dr. Agnes Lacreuse, Educator (co-awardee) and Governor Maura Healey (Government Leader)]

ABOUT MSMR: Founded in 1953, the Massachusetts Society for Medical Research (MSMR) is a non-profit organization supporting biomedical sciences across New England. MSMR represent the colleges, universities, hospitals, biotechnology firms, pharmaceutical companies and others located throughout the region that conduct the medical research that leads to the discovery of new life saving medications, medical devices and new health care treatment protocols. It is the nation’s oldest state-based non-profit association serving the biomedical research community.

For more information, visit the MSMR website.